TRAVERE THERAPEUTICS, INC. (TVTX)
Clinical trial NCT03406611 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-12-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2027-07-01 4. enrollment: 32 → 39 participants
Clinical trial NCT03406611 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-12-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2027-07-01 4. enrollment: 32 → 39 participants
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical